Max Robotics — Global Service Robot Directory + US Certification

About

David M. DiBardino is a leading pulmonary medicine researcher whose work bridges advanced diagnostic bronchoscopy and innovative cancer therapies. His primary research areas include interventional pulmonology, endobronchial ultrasound (EBUS), and pulsed electric field (PEF) ablation for metastatic lung cancer. DiBardino’s major contributions center on expanding the safety and efficacy of minimally invasive pulmonary procedures. His 2024 study on practices and perspectives among pediatric pulmonologists, with 8 citations, provides critical insights into the adoption of advanced bronchoscopic techniques like CT navigation and robotic bronchoscopy in pediatric care. More recently, his 2025 investigation into the safety of PEF ablation before standard-of-care therapy in metastatic cancer patients, garnering 5 citations, demonstrates a pioneering approach to combining diagnostic biopsy with therapeutic intervention. This work has significant implications for reducing treatment delays and improving outcomes in oncology. DiBardino’s research is notable for its translational impact, directly informing clinical guidelines and procedural standards. His dedication to advancing both pediatric and adult interventional pulmonology positions him as a key figure in shaping the future of respiratory medicine.